Visual inspection of survival curves also showed a trend toward longer OS of the TNBC subgroup compared to the HR+/HER2− subgroup, but this did not reach statistical significance due to the small number of patients with TNBC (HR, 0.27; 95% CI, 0.06–1.14, p = 0.075).
← all excerpts
Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer.
1
—
—